Back To Black - Seven In 10 Brits Prefer A Traditional Brew, Says New UK Tea and Infusions Census Study
LONDON, May 19, 2025 /PRNewswire/ --The nation's favourite traditional brew is holding strong in the popularity stakes among Brits – world renowned for being a nation of tea lovers – according to the latest real-world New Tea Census Study[1] of over 1,000 Brits commissioned by the UK Tea and Infusions Association (UKTIA) – www.tea.co.uk.
"The publishing of our latest New Tea Census Study coincides with International Tea Day (21st of May) this year – a day designated by the United Nations to raise awareness about tea's history, cultural significance, and economic importance," comments Dr Sharon Hall, Chief Executive of the UKTIA. "As a nation with a long history of tea drinking, Brits are ideally placed to raise a cup or two to celebrate. What's more, the Tea Census Study data clearly shows that the majority of us stick to tradition when it comes to our brew choice," notes Dr Sharon Hall further.
Dr Sharon Hall continues: "For 71% of us, traditional black tea, with or without milk, holds strong as our main infusion of choice, with one in six (16%) more likely to opt for herbal infusion, and one in eight (13%) predominantly choosing green tea, according to the UKTIA Tea Census real-world data."
However, interestingly, the split between our preferred infusion changes with age, according to the UKTIA Tea Census Study.
"We found some noteworthy differences between the older and younger generations," says Dr Sharon Hall, adding, "For example, among the 18-24 age group, two thirds (63%) said they mainly drink black tea, while around a fifth (20%) are experimenting with a range of herbal infusions or drinking green tea."
She continues, "That's compared with the 65+ age group, among whom over four fifths (86%) mainly drink black tea, but fewer than one in 10 choosing herbal or green tea."
Additionally, more women than men were likely to deviate from tradition when it comes to their main brew of choice, with one in five women (19%) opting for herbal infusions compared to just one in eight (12%) men.
"Something that unites us all, however," says Dr Sharon Hall, "…is the vast majority across all the age groups (93% overall) prefer the convenience of making their brew with a tea bag rather than preparing a loose-leaf infusion."
Perhaps this tendency to prefer tea bags reflects our need for convenience in our ever faster paced modern world, with the UKTIA Tea Census Study data also suggesting that perhaps many of us are prone to making our tea in too much of a rush.
"Three quarters (73%) of those surveyed admitted to leaving their tea to brew for less than the 3-4 minutes we at the UKTIA would recommend for the ideal cup of regular black tea," says Dr Sharon Hall.
In fact, the ideal tea brewing time of 3-4 minutes suggested by the UKTIA applies to a wide variety of different teas, including Darjeeling, Assam, Ceylon, and Earl Grey black teas.[2]
When asked how long they left their tea to brew before drinking it, the top answer overall was just 1-2 minutes, while nearly a fifth (18%) said less than a minute, and 16% said 2-3 minutes.
Dr Sharon Hall comments, "Only one in 14 (7%) Brits let their tea brew for what we at the UK Tea and Infusions Association would generally regard to be the required time for most types of tea: 3-4 minutes. That sadly leaves the vast majority of Brits missing out on the perfect tasting cuppa. Plus, leaving tea to brew for three to five minutes will ensure the optimal amount of polyphenol compounds are released, such as flavan-3-ols and theaflavins. Polyphenols are natural plant compounds that contribute to tea's flavour and mouthfeel, and they provide nutritional benefits like fruit and vegetables.
Dr Sharon Hall continues: "Although younger generations are experimenting with a range of teas more than their parents and grandparents, our new Tea Census Study data clearly shows that the nation's favourite is still a traditional brew of regular black tea."
In summary Dr Sharon Hall notes: "However, many of us would benefit from slowing down to make the ideal cuppa – not only to enjoy the best of its flavour profile but also to take time out of our busy days. International Tea Day 2025 is the perfect time to set this new habit in place."
How to make a perfect brew
Want to know what makes the best brew? UKTIA's Dr Sharon Hall has put together a few simple steps to help ensure you make the best brew this International Tea Day and beyond:
Use a good quality teabag or loose-leaf tea and store your tea in a cool, dry place. Avoid storing tea next to strongly flavoured or perfumed foods.
Always use freshly drawn water and consider using a water filter. Dr Sharon Hall explains, "In some parts of the country the tap water is hard or soft and this can affect the taste of the tea."
Use one teabag or one rounded teaspoon of loose tea for each cup or mug.
Smart boil. Using your mug, measure out just the water you need for one or two cuppas and only boil that.Dr Sharon Hall notes; "This will help save on energy costs and will ensure a good flavour tea which develops best when made with freshly boiled water. The lack of oxygen bubbles in re-boiled water can give the tea a flat taste."
Allow the tea to brew for the recommended time before pouring. Always read the instructions on the pack and if you're brewing tea from a bag in a mug, adding milk last is best.
Most black teas should be brewed for three to four minutes, while Lapsang Souchong black tea tastes best after four to five minutes. Brew green tea for three to four minutes and oolong tea for three to five minutes, depending on your strength preference.
Remove the bag after brewing, before adding the milk.
Put your feet up, relax and enjoy.
To discover more about tea, see: https://www.tea.co.uk/
For more information, SEE: https://www.tea.co.uk/
What is the UK Tea & Infusions Association? The United Kingdom Tea & Infusions Association (UKTIA) is an independent, non-profit making body that works in support of the industry and is dedicated to promoting tea and herbal infusions and their unique story to consumers, the media, and key stakeholders. UKTIA works on behalf of the world's major tea producing and exporting countries, UK tea packers and allied UK companies who support the tea and herbal infusions supply chains. The UKTIA provides support and information of a technical, scientific, and regulatory nature. UKTIA is the voice of the British tea and herbals industry.
The UK TEA & INFUSIONS ASSOCIATION is the trade association for the UK tea industry.
[1] Perspectus Global; April 2025;1015 respondents
[2] https://www.tea.co.uk/make-a-perfect-brew
View original content:https://www.prnewswire.com/news-releases/back-to-black---seven-in-10-brits-prefer-a-traditional-brew-says-new-uk-tea-and-infusions-census-study-302458012.html
SOURCE UK Tea and Infusions Association
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Eli Lilly to hike U.K. Mounjaro Price 170% after Trump push
Eli Lilly is raising the price of the weight loss drug Mounjaro in the U.K., after President Donald Trump ramped up pressure on drugmakers to lower U.S. prices and raise them abroad. The price of the drug is expected to rise by up to 170% in September, increasing the cost of a monthly supply at the highest dose from £122 ($165) to £330 ($447). The company said it had agreed with the British government to raise prices while 'maintaining access' for patients covered by the U.K.'s National Health Service. Last month, Trump wrote to 17 of the world's biggest drugmakers , including Eli Lilly, Novo Nordisk, and Pfizer, demanding they slash prices for U.S. consumers as part of his 'most favored nation' policy. The scheme aims to bring down drug prices by tying charges in the U.S. to lower ones abroad. Eli Lilly said Thursday that it has 'intensified efforts to align prices across developed countries, especially in Europe'. 'We are continuing to work with certain governments and expect to make any necessary pricing adjustments by September 1, while providing continued access for patients,' it said. Prescription drug prices in the U.S. are often two to three times higher on average than those in other developed nations, according to the nonprofit Commonwealth Fund. The list price for a month's supply of Mounjaro in the U.S. is $1,079.77 before insurance. Eli Lilly added that it supports Trump's goal of keeping the U.S. the 'world's leading destination for biopharmaceutical research and manufacturing, and the objective of more fairly sharing the costs of breakthrough medical research across developed countries.' 'This rebalancing may be difficult, but it means the prices for medicines paid by governments and health systems need to increase in other developed markets like Europe in order to make them lower in the US,' it said. Trump wrote in July that he would 'deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices' if companies did not comply with his demands, saying other countries had been 'freeloading on U.S. innovation'. Meanwhile, the pharmaceutical industry is bracing for planned U.S. tariffs of medicines imported into the country. Eli Lilly said Thursday that it opposes the tariffs, saying they will raise costs and limit access to drugs. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 hours ago
- Yahoo
Pensioner died after hospital missed bleed on the brain, then made it worse
A pensioner was given blood thinning medication after an out-of-hours CT scan service 'missed' the fact he was suffering from bleeding on the brain, a coroner said. Kenneth Edwards died at Stepping Hill Hospital in Stockport on March 23 this year. The previous day the 85-year-old had been taken into hospital, where he was given the first of two CT scans, after falling in the street. The following morning Mr Edwards fell again at the hospital and underwent another CT scan of his head to see if the fall had caused any bleeding. But while waiting for the results he was given blood thinning medication. READ MORE: The Peak District road named one of Britain's most dangerous roads set for £7.6m improvement READ MORE: "Everyone was scared": Passengers spot 'cracked' window on Manchester Ryanair flight When the results came back they showed Mr Edwards had suffered a brain haemorrhage. He died later that day. An inquest at Stockport coroners court earlier this month concluded Mr Edwards 'died as a consequence of bleeding to the brain caused by two falls, which was contributed to by blood-thinning medication administered to him whilst in hospital'. Never miss a story with the MEN's daily Catch Up newsletter - get it in your inbox by signing up here Now, assistant coroner Benjamin Myers KC has written to the chief executive of Stockport NHS Foundation Trust to raise urgent concerns about Mr Edwards' care, saying 'there is a risk that future deaths could occur unless action is taken'. In a prevention of future deaths report Mr Myers writes that as the first CT scan took place at 6.50pm, out of normal hospital hours, it was dealt with by a company called Medica. But, Mr Myers writes, the company failed to identify Mr Edwards was suffering from bleeding on the brain. And evidence showed it wasn't the first time 'that detail had been missed on a scan reported upon by Medica', Mr Myers said. He adds: "Had the haematoma properly been identified at the time the first scan was reported, appropriate steps could have been taken to deal with it at a relatively early stage. Furthermore, this would have identified circumstances at an early stage of Kenneth Edwards's treatment that militated against the administration of blood-thinning medication." Join the Manchester Evening News WhatsApp group HERE But Mr Myers also said the administration of blood thinners 'should not have happened' while Mr Edwards was still waiting on the results of the second CT scan. He added: "Whilst the treating clinician/s could not have known about the bleed that had not been identified on the first scan, they should have known that such medications were contra-indicated where the results of the second scan to identify brain bleeding were awaited." In a statement Stockport NHS Foundation Trust said: "We offer our sincere condolences to the family of Kenneth Edwards, and we are in communication with them. We will be responding to the coroners concerns on these matters."
Yahoo
4 hours ago
- Yahoo
Mounjaro price increase sees patients switch to cheaper Wegovy
Following news that the manufacturer price for Mounjaro will be increasing by 170%, pharmacies have been inundated by people looking to switch to Wegovy. Google Trends shows a +5,500% increase for 'can I swap from Mounjaro to Wegovy' since last Thursday, highlighting that people in the UK and Northern Ireland are searching for a more cost-effective treatment to continue their weight loss journey. There has also been issues with some pharmacies running out of stock of Moumjaro, as patients try to get supplies before the price hike. Mounjaro users report surprising side effect - pharmacists share their tips — Bucks Free Press (@bucksfreepress) August 8, 2025 'With Mounjaro's price rise looming, it's not surprising that patients are exploring alternatives," says Jason Murphy, Head of Pharmacy at Chemist4U. "Wegovy offers a safe, less expensive and almost equally effective weight loss solution and is a very good option to consider if Mounjaro becomes unaffordable. 'However, switching should always be as part of a conversation with your pharmacist or GP. Our role is to guide patients through the process, tailoring advice to their health history, so they can continue their weight loss journey with confidence.' Both medications are part of a group called GLP-1 receptor agonists What is Wegovy? Is it the same as Ozempic? Wegovy and Mounjaro are both weekly injections originally designed for type 2 diabetes but are powerful weight-loss drugs. Wegovy (the brand name for semaglutide) works by mimicking a gut hormone (GLP-1) that curbs appetite and slows digestion. Semaglutide is also branded as Ozempic for managing type 2 diabetes, but is not prescribed for weight-loss in the UK. Mounjaro goes a step further by also targeting a second hormone, GIP. 'When moving from Mounjaro to Wegovy, it's not a one-size-fits-all process," says Jason. "Your starting Wegovy dose should always reflect the Mounjaro dose you were previously on, alongside your overall health, and how well you tolerated treatment. That's why a pharmacist's review is essential; it ensures the transition is safe, effective, and tailored to your individual needs.' Who is eligible for Wegovy? For those who have not taken a weight loss injection before, Wegovy has the same eligibility criteria as Mounjaro. This means a BMI of 30 or higher, or a BMI of 27 or higher with a pre-existing medical condition that is affected by weight (e.g., cardiovascular disease or high blood pressure). This might be more complicated for patients who have already lost weight on Mounjaro and are now below a BMI of 30, or 27, and now looking to continue their weight-loss, but experts recommend speaking a doctor or pharmacist. How do you switch from Mounjaro to Wegovy? Jason says that when switching, it's important to not stop Mounjaro until your prescriber confirms the switch to Wegovy is possible. But, he cautions: 'Please note that the manufacturer recommends leaving 30 days from your last dose of Mounjaro and your first dose of Wegovy, to further reduce the risk of side effects, however we understand this could result in stalling your weight loss journey or potential weight gain.' He adds that if you've already lost weight while taking Mounjaro, or are using it to maintain your weight, and are now below the eligibility criteria, you may still be able to switch to Wegovy; a clinical team will review your medical history and decide if it's safe and suitable. Recommended reading: When will Mounjaro be rolled out on the NHS? Why am I not losing weight on Mounjaro? Users' questions answered. Mounjaro 'golden dose' revealed in new survey What are the Wegovy and Mounjaro side effects? People respond to medications in different ways, and even though Mounjaro and Wegovy share similar ingredients, some people may tolerate one better than another. Jason adds: 'There are no 'withdrawal' symptoms in the usual sense. Some people notice their appetite increases as the medicine wears off, and any side effects usually settle after stopping. If you feel unwell or are unsure what to expect, speak to your prescriber. 'It's unlikely you'll gain weight when switching, as the effects of Mounjaro will continue during the seven days after your final dose. You will then immediately start taking Wegovy, which will continue to work in the same way. This means you can continue losing weight while switching, especially if you're sticking to your diet and exercise plan.'
